389650 — NextBioMedical Co Balance Sheet
0.000.00%
- KR₩700bn
- KR₩681bn
- KR₩10bn
Annual balance sheet for NextBioMedical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 14,797 | 14,290 | 41,609 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 505 | 1,216 | 2,244 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 17,521 | 17,968 | 46,888 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 11,735 | 11,428 | 11,270 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 32,136 | 29,643 | 58,844 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 30,968 | 33,786 | 11,884 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Funded Status | |||
| Total Liabilities | 32,390 | 35,544 | 13,653 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | -254 | -5,901 | 45,191 |
| Total Liabilities & Shareholders' Equity | 32,136 | 29,643 | 58,844 |
| Total Common Shares Outstanding |